Sound waves could spot stroke dangers early

NCT ID NCT07013396

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study will use transcranial Doppler (TCD) ultrasound to measure blood flow in the brains of 100 people who had a stroke and underwent endovascular therapy (clot removal). The goal is to see if TCD readings can predict complications like bleeding or brain swelling in the days after treatment. Participants will have TCD exams daily for three days after their procedure. If TCD proves useful, it could help doctors catch problems earlier and improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial Doppler (TCD) ultrasound measurement
What this could lead to
If successful, this could help doctors identify stroke patients at risk of worsening after treatment, allowing earlier intervention and better outcomes.
What could go wrong
This is an early observational study with only 100 participants, so results may not apply to all stroke patients. TCD may not detect all complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Virginia Commonwealth University

    Richmond, Virginia, 23235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.